Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,530,369 papers from all fields of science
Search
Sign In
Create Free Account
levonantradol
A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Levonantradol HCl
Broader (1)
nantradol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Levonantradol: asymmetric synthesis and structural analysis.
Andrey E. Sheshenev
,
Ekaterina V. Boltukhina
,
K. K. Hii
Chemical Communications
2013
Corpus ID: 27548717
The first asymmetric synthesis of a synthetic cannabinoid levonantradol was accomplished, and the 3-D solution structure of its…
Expand
1992
1992
The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity
A. Lichtman
,
Peter B. Smith
,
B. Martin
Pain
1992
Corpus ID: 28862905
1987
1987
[3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs.
B. Koe
,
Elena Kondratas
,
L. Russo
European Journal of Pharmacology
1987
Corpus ID: 4621476
1985
1985
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
M. L. Citron
,
T. Herman
,
+5 authors
M. Cohen
Cancer treatment reports
1985
Corpus ID: 36655372
The antiemetic efficacy of im levonantradol, a synthetic cannabinoid, given at a dose of 1 mg every 4 hours, was compared to oral…
Expand
1983
1983
Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
R. Stuart-Harris
,
C. Mooney
,
I. Smith
Clinics in oncology
1983
Corpus ID: 23460955
Twenty-three patients with severe nausea and vomiting refractory to conventional anti-emetic therapy were entered into an open…
Expand
1981
1981
Oral Levonantradol in the Treatment of Chemotherapy‐Induced Emesis: Preliminary Observations
R. Diasio
,
D. Ettinger
,
BARBARA E. Satterwhite
Journal of clinical pharmacology
1981
Corpus ID: 21976921
Abstract: Levonantradol, a new synthetic cannabinoid, was examined for antiemetic effectiveness in 27 patients with refractory…
Expand
1981
1981
Effects of Levonantradol on Habituation of Startle in Rats
M. Geyer
Journal of clinical pharmacology
1981
Corpus ID: 1077983
Abstract: Levonantradol, a nonopioid analgetic related to cannabinoids, produced a dose‐dependent impairment of the habituation…
Expand
1981
1981
Levonantradol‐Induced Inhibition of Acetylcholine Turnover in Rat Hippocampus and Striatum
E. Costa
,
D. Cheney
,
T. F. Murray
Journal of clinical pharmacology
1981
Corpus ID: 8869052
Abstract: The effects of levonantradol, a structurally novel cannabinoid‐related analgesic, on the turnover rate of acetylcholine…
Expand
1981
1981
Effects of Morphine, Levonantradol, and N‐Methyllevonantradol on Shock Intensity Discrimination
L. Dykstra
Journal of clinical pharmacology
1981
Corpus ID: 23363249
Abstract: The effects of morphine, levonantradol, and N‐methyllevonantradol administered to squirrel monkeys by intramuscular…
Expand
1981
1981
Levonantradol Potentiates the Anticonvulsant Effects of Diazepam and Valproic Acid in the Kindling Model of Epilepsy
C. Ehlers
,
S. Henriksen
,
F. E. Bloom
Journal of clinical pharmacology
1981
Corpus ID: 46509345
Abstract: The anticonvulsant effects of the cannabinoid derivative levonantradol and its ability to potentiate the anticonvulsant…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE